Home > Publications Database > Basophils activate splenic B cells and dendritic cells via IL-13 signaling in acute traumatic brain injury. > print

001     282965
005     20260212155352.0
024 7 _ |2 pmc
|a pmc:PMC12709802
024 7 _ |2 doi
|a 10.1186/s12974-025-03621-1
024 7 _ |2 pmid
|a pmid:41408561
037 _ _ |a DZNE-2025-01417
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Olde Heuvel, Florian
|b 0
245 _ _ |a Basophils activate splenic B cells and dendritic cells via IL-13 signaling in acute traumatic brain injury.
260 _ _ |a London
|b BioMed Central
|c 2025
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1766152797_31936
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a Peripheral consequences following traumatic brain injury (TBI) are characterized by both systemic inflammatory responses and autonomic dysregulation. One of the main immune regulatory organs, the spleen, shows high interaction with the brain which is controlled by both circulating mediators as well as autonomic fibers targeting splenic immune cells. The brain-spleen axis does not function as a one-way street, it also shows reciprocal effects where the spleen affects neuroinflammatory and cognitive functions post injury. To date, systemic and splenic inflammatory responses are measured by cells or mediators located in circulation. Nevertheless, most of the signaling and inflammation post injury takes place in the organs.We set out to investigate the early (3 h) signaling landscape in the spleen following a moderate severity closed head injury model to wild-type animals aged p60-90. Using phospho-proteomic signaling approaches, immunofluorescence stainings, Enzyme-Linked Immunosorbent Assay (ELISA), super-resolution microscopy and single mRNA in situ hybridization we investigated novel molecular and cellular players in the spleen involved in immune modulation after a head injury.Based on the signaling signature, we found a rapid influx of basophil granulocytes towards the spleen, via a recruitment mechanism that includes CXCL1 expressed by B-cells and dendritic cells (DCs). The basophils in turn seem to activate B cells and dendritic cells via the IL-13/IL-13Ra1 signaling pathway and enhance protein translation through the long non-coding RNA NORAD. The early recruitment of basophils and subsequent activation of B cells and DCs, is short lived and sets at 3dpi. Interestingly, the rapid recruitment of basophils is inhibited by ethanol intoxication in TBI, with a subsequent prevention of IL-13Ra phosphorylation and NORAD increase in B-cells and DCs.Basophils recruitment to the spleen may serve as an early mediator of systemic inflammatory responses to TBI with potential implications for research on biomarkers and therapeutic targets.
536 _ _ |0 G:(DE-HGF)POF4-352
|a 352 - Disease Mechanisms (POF4-352)
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |2 Other
|a B-cell
650 _ 7 |2 Other
|a Basophil
650 _ 7 |2 Other
|a Dendritic cell
650 _ 7 |2 Other
|a IL-13
650 _ 7 |2 Other
|a Spleen
650 _ 7 |2 Other
|a Traumatic brain injury
650 _ 7 |2 NLM Chemicals
|a Interleukin-13
650 _ 2 |2 MeSH
|a Animals
650 _ 2 |2 MeSH
|a Brain Injuries, Traumatic: immunology
650 _ 2 |2 MeSH
|a Brain Injuries, Traumatic: metabolism
650 _ 2 |2 MeSH
|a Brain Injuries, Traumatic: pathology
650 _ 2 |2 MeSH
|a Mice
650 _ 2 |2 MeSH
|a Spleen: immunology
650 _ 2 |2 MeSH
|a Spleen: metabolism
650 _ 2 |2 MeSH
|a Spleen: pathology
650 _ 2 |2 MeSH
|a Signal Transduction: physiology
650 _ 2 |2 MeSH
|a B-Lymphocytes: metabolism
650 _ 2 |2 MeSH
|a B-Lymphocytes: immunology
650 _ 2 |2 MeSH
|a Interleukin-13: metabolism
650 _ 2 |2 MeSH
|a Interleukin-13: immunology
650 _ 2 |2 MeSH
|a Basophils: metabolism
650 _ 2 |2 MeSH
|a Basophils: immunology
650 _ 2 |2 MeSH
|a Mice, Inbred C57BL
650 _ 2 |2 MeSH
|a Dendritic Cells: metabolism
650 _ 2 |2 MeSH
|a Dendritic Cells: immunology
650 _ 2 |2 MeSH
|a Male
700 1 _ |a Zhang, Jin
|b 1
700 1 _ |a Sun, Fan
|b 2
700 1 _ |a Krishnamurthy, Sruthi Sankari
|b 3
700 1 _ |0 P:(DE-2719)9001770
|a Yartas, Gizem
|b 4
|u dzne
700 1 _ |a Özkan, Burak
|b 5
700 1 _ |a Pagliarini, Marica
|b 6
700 1 _ |a Voehringer, David
|b 7
700 1 _ |a O'Meara, Caitlin C
|b 8
700 1 _ |a Schäfer, Michael K E
|b 9
700 1 _ |a Huber-Lang, Markus
|b 10
700 1 _ |0 P:(DE-2719)2812851
|a Roselli, Francesco
|b 11
|e Last author
|u dzne
773 _ _ |0 PERI:(DE-600)2156455-3
|a 10.1186/s12974-025-03621-1
|g Vol. 22, no. 1, p. 290
|n 1
|p 290
|t Journal of neuroinflammation
|v 22
|x 1742-2094
|y 2025
856 4 _ |u https://pub.dzne.de/record/282965/files/DZNE-2025-01417.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/282965/files/DZNE-2025-01417.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:282965
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-HGF)0
|6 P:(DE-2719)9001770
|a External Institute
|b 4
|k Extern
910 1 _ |0 I:(DE-588)1065079516
|6 P:(DE-2719)2812851
|a Deutsches Zentrum für Neurodegenerative Erkrankungen
|b 11
|k DZNE
913 1 _ |0 G:(DE-HGF)POF4-352
|1 G:(DE-HGF)POF4-350
|2 G:(DE-HGF)POF4-300
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|v Disease Mechanisms
|x 0
914 1 _ |y 2025
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b J NEUROINFLAMM : 2022
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2024-04-10T15:42:04Z
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2024-04-10T15:42:04Z
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b J NEUROINFLAMM : 2022
|d 2024-12-16
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2024-12-16
915 _ _ |0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
|a Creative Commons Attribution CC BY 4.0
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2024-12-16
920 1 _ |0 I:(DE-2719)1910001
|k AG Roselli
|l Metabolic Changes in Neurodegeneration
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1910001
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21